Back to Search
MICHAEL BOOKMAN, M.D.
M.D.
Medical Oncology Physician
NPI: 1972570836IndividualAccepts Medicare
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
MD042886(PA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD042886E(PA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 1980
Research & Publications (20)
Uterine Neoplasms. Clinical Practice Guidelines in Oncology.
PMID 19460278·J Natl Compr Canc Netw·2009
6-review
Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer.
PMID 19200415·J Natl Compr Canc Netw·2009
8-other
Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: a Gynecologic Oncology Group study.
PMID 18962846·Gynecol Oncol·2009
3-trial
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.
PMID 19224846·J Clin Oncol·2009
3-trial
Selecting high priority quality measures for breast cancer quality improvement.
PMID 18665055·Med Care·2008
8-other
Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group.
PMID 18597837·Gynecol Oncol·2008
3-trial
Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.
PMID 18472360·Int J Radiat Oncol Biol Phys·2008
8-other
A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study.
PMID 17368526·Gynecol Oncol·2007
3-trial
Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer.
PMID 17070570·Gynecol Oncol·2006
8-other
Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
PMID 16904166·Gynecol Oncol·2006
4-observational
Sequence dependence of hematologic toxicity using carboplatin and topotecan for primary therapy of advanced epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.
PMID 16631245·Gynecol Oncol·2006
3-trial
The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers.
PMID 16421417·J Clin Oncol·2006
4-observational
3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.
PMID 16239235·Ann Oncol·2005
8-other
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).
PMID 16239238·Ann Oncol·2005
8-other
Integration of new or experimental treatment options and new approaches to clinical trials.
PMID 16239234·Ann Oncol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 N CAMPBELL AVE, ROOM 1903
TUCSON, AZ 85724 - Phone
- (520) 626-3600
Quick Facts
- NPI
- 1972570836
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile